← Back to Search

Normothermic Machine Perfusion (NMP) for Liver Transplant

N/A

Waitlist Available

Research Sponsored by OrganOx Ltd.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will continue to collect data on effectiveness and safety to support the goals of the original study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of Early Allograft Dysfunction (EAD)

Secondary outcome measures

Incidence of Biliary Investigations/Interventions

Incidence of Ischemia-reperfusion Injury Via Analysis of Post-reperfusion Biopsies

Incidence of Primary Non-function

+14 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Normothermic Machine Perfusion (NMP)Experimental Treatment1 Intervention

Following the routine retrieval procedure of the liver, it will be placed on the OrganOx metra for Normothermic Machine Perfusion (NMP) for transport per the Investigational Plan and the Instructions for Use.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Normothermic Machine Perfusion (NMP)

2016

N/A

~270

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

North American Science Associates (NAMSA)UNKNOWN

2 Previous Clinical Trials

436 Total Patients Enrolled

OrganOx Ltd.Lead Sponsor

3 Previous Clinical Trials

607 Total Patients Enrolled

North American Science Associates Ltd.NETWORK

3 Previous Clinical Trials

451 Total Patients Enrolled

Media Library

Normothermic Machine Perfusion (NMP) Clinical Trial Eligibility Overview. Trial Name: NCT04862156 — N/A

Liver Transplant Research Study Groups: Normothermic Machine Perfusion (NMP)

Liver Transplant Clinical Trial 2023: Normothermic Machine Perfusion (NMP) Highlights & Side Effects. Trial Name: NCT04862156 — N/A

Normothermic Machine Perfusion (NMP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04862156 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to apply for this experiment currently?

"The information on clinicaltrials.gov demonstrates that this research is no longer recruiting subjects, with their data being last modified in August of 2022. Despite this trial not accepting new participants at present, there are 52 other studies seeking volunteers to join immediately."

Answered by AI

Are there any US-based sites that are implementing this investigation?

"This research is being conducted in various parts of the United States, with a notable presence at University of Pennsylvania, University of Wisconsin-Madison and Duke University. Additionally, there are 7 other sites participating."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

WP02 Continued Access Study

2021. "WP02 Continued Access Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04862156.